Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Korean Medical Science|August 30, 2008
Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancerJunyl Hwang, Sang-Hee Cho, Hyun Jeong Shim, et al.
The Korean Journal of Internal Medicine|October 20, 2021
The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myelomaKa-Won Kang, Byung-Hyun Lee, Min Ji Jeon, et al.
Cancer Medicine|July 8, 2020
Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstimKa-Won Kang, Byung-Hyun Lee, Min Ji Jeon, et al.
Plos One|September 13, 2023
Cytomegalovirus reactivation under pre-emptive therapy following allogeneic hematopoietic stem cell transplant: Pattern, survival, and risk factors in the Republic of KoreaKa-Won Kang, Min Ji Jeon, Eun Sang Yu, et al.
Therapeutic Advances in Hematology|February 14, 2022
Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agentsKa-Won Kang, Byung-Hyun Lee, Min Ji Jeon, et al.
Cellular Reprogramming|August 12, 2010
The efficacy of human placenta as a source of the universal feeder in human and mouse pluripotent stem cell cultureYong Park, Seung Jin Lee, In Young Choi, et al.
Frontiers in Oncology|August 2, 2021
Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma PatientsByung-Hyun Lee, Ka-Won Kang, Min Ji Jeon, et al.
International Journal of Medical Sciences|February 16, 2023
Prognostic outcomes of cytomegalovirus reactivation after autologous stem cell transplantationByung-Hyun Lee, Min Ji Jeon, Eun Sang Yu, et al.
Stem Cells and Development|March 6, 2010
Undifferentiated propagation of the human embryonic stem cell lines, H1 and HSF6, on human placenta-derived feeder cells without basic fibroblast growth factor supplementationYong Park, In Young Choi, Seung Jin Lee, et al.
Scientific Reports|November 5, 2024
Busulfan and cyclophosphamide for autologous stem cell transplantation in patients with multiple myeloma after proteasome inhibitor and/or immunomodulatory drug treatmentMin Ji Jeon, Eun Sang Yu, Dae Sik Kim, et al.
Pageof 7